CTSO — Cytosorbents Corp
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1175151 ·
Last close
$4.52
Market Cap
$14.24M
52W High
$17.00
52W Low
$2.84
ADV30
55,469
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 9,633,000 | 7,049,000 | -2,368,000 | -4,417,000 | 37,960,000 | 4,413,000 | 38,711,000 |
| Mar 2026 | 8,864,000 | 6,130,000 | -3,044,000 | -5,129,000 | 40,562,000 | 4,813,000 | 38,368,000 |
| Dec 2025 | 9,234,000 | 6,804,000 | -3,875,000 | -5,497,000 | 44,182,000 | 6,249,000 | 38,279,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-9,147,000
Investing CF
$-275,000
Financing CF
$2,478,000
CapEx
$-623,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-5.80
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-321,754,000
Inventory
$3,686,000
Receivables
$6,786,000
ST Investments
—
EBIT TTM
$-15,498,000
Pretax Income TTM
$-18,614,000
Interest Exp TTM
$3,116,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$37,216,000
EBITDA
$-10,349,000
Free Cash Flow
$-3,508,000
Enterprise Value
$45,154,100
Total Cash
$4,413,000
Total Debt
$29,426,000
Shares Out
3,151,101
Trailing EPS
$-5.80
Book Value
$-0.24
ROE
-336.2%
ROA
-17.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 37,063,000 | -14,239,000 | -8,198,000 | 44,182,000 | 38,279,000 | 5,903,000 | -12,377,000 |
| Dec 2024 | 35,595,000 | -16,452,000 | -20,719,000 | 47,372,000 | 36,265,000 | 11,107,000 | -14,428,000 |
| Dec 2023 | 31,084,953 | -31,948,620 | -29,246,760 | 52,956,322 | 29,475,108 | 23,481,214 | -21,655,136 |
| Dec 2022 | 29,359,910 | -31,521,879 | -32,812,583 | 63,231,530 | 27,856,557 | 35,374,973 | -28,234,282 |
TTM Snapshot
Revenues TTM
$37,215,762
NetIncome TTM
$-18,212,642
OpCashFlow TTM
—
Assets (Latest)
$37,960,000
Forward EPS
$0.00
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SNWV | SANUWAVE Health, Inc. | $14.62M | $1.70 | — |
| MODD | Modular Medical, Inc. | $14.67M | $1.80 | — |
| PAVM | PAVmed Inc. | $14.86M | $1.51 | — |
| PETV | PetVivo Holdings, Inc. | $13.28M | $0.35 | — |
| DRIO | DarioHealth Corp. | $12.98M | $1.15 | — |
News headlines (Yahoo Finance, 1h cache)
CTSO: CytoSorbents Reaches Positive Operating Cash Flow in the 3rd Quarter
2026-11-17 09:05 · Yahoo
Cytosorbents Corporation Q3 2026 Earnings Call Summary
2026-11-13 13:30 · Yahoo
Cytosorbents (CTSO) Q3 2026 Earnings Call Transcript
2026-11-13 06:59 · Yahoo
CytoSorbents Corp (CTSO) Q3 2026 Earnings Call Highlights: Cash Flow Breakeven, Margin ...
2026-11-13 05:03 · Yahoo
CytoSorbents Reports Third Quarter 2026 Financial Results, Achieves Operating Cash Flow Breakeven, and Provides Business and Regulatory Update
2026-11-12 22:16 · Yahoo
CytoSorbents: Q3 Earnings Snapshot
2026-11-12 22:15 · Yahoo
CytoSorbents to Participate at the 2026 Jefferies Global Healthcare Conference in London
2026-11-09 12:00 · Yahoo
CytoSorbents to Report Third Quarter 2026 Financial Results and Recent Business Highlights
2026-10-29 11:00 · Yahoo
CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care
2026-09-30 11:00 · Yahoo
CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-10 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.